Holen Sie sich die Stockscreener-App
117.27
3.52%
-4.28
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$121.55
Offen:
$121.55
24-Stunden-Volumen:
938.82K
Relative Volume:
1.17
Marktkapitalisierung:
$12.00B
Einnahmen:
$12.82B
Nettoeinkommen (Verlust:
$936.34M
KGV:
10.92
EPS:
10.74
Netto-Cashflow:
$1.47B
1W Leistung:
-2.41%
1M Leistung:
-6.84%
6M Leistung:
-19.35%
1J Leistung:
-26.86%
1-Tages-Spanne:
$116.72
$121.80
1-Wochen-Bereich:
$116.72
$125.68
52-Wochen-Spanne:
$115.39
$179.60
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Vergleichen Sie DVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
117.27 | 8.58B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
477.10 | 107.86B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
192.40 | 16.95B | 20.69B | 2.40B | 1.55B | 15.62 |
|
CHE
Chemed Corp
|
432.38 | 6.15B | 2.49B | 308.74M | 315.04M | 20.53 |
|
UHS
Universal Health Services Inc
|
226.50 | 14.06B | 16.08B | 1.20B | 1.06B | 17.82 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
DaVita at Wolfe Conference: Navigating Challenges and Growth - Investing.com
Published on: 2025-11-17 07:03:51 - newser.com
Has DaVita Inc. formed a bullish divergenceForecast Cut & Free Technical Pattern Based Buy Signals - newser.com
Why DaVita Inc. stock stays on buy lists2025 Major Catalysts & AI Powered Buy/Sell Recommendations - newser.com
How DaVita Inc. (TRL) stock expands through international markets2025 Trading Volume Trends & AI Driven Stock Reports - newser.com
Using AI based signals to follow DaVita Inc.Bond Market & Weekly Momentum Stock Picks - newser.com
Is a relief rally coming for DaVita Inc. holders2025 Market Trends & Detailed Earnings Play Strategies - newser.com
Sentiment analysis tools applied to DaVita Inc.July 2025 Macro Moves & Capital Protection Trading Alerts - newser.com
Will DaVita Inc. stock profit from fiscal stimulusWeekly Trade Analysis & Verified Swing Trading Watchlists - newser.com
Will DaVita Inc. rebound enough to break evenMarket Sentiment Report & Safe Swing Trade Setups - newser.com
DaVita Inc.’s volatility index tracking explainedRate Cut & Verified Momentum Stock Ideas - newser.com
Can DaVita Inc. (TRL) stock attract ESG investmentsAnalyst Downgrade & High Conviction Trade Alerts - newser.com
Is DaVita Inc. stock bottoming outTrade Risk Report & Safe Entry Point Identification - newser.com
DaVita Inc. to Participate in Fireside Chat with Wolfe Research - The Malaysian Reserve
Will DaVita Inc. stock outperform tech sector in 2025Weekly Trade Summary & AI Optimized Trading Strategy Guides - newser.com
Unpacking Q3 Earnings: DaVita (NYSE:DVA) In The Context Of Other Outpatient & Specialty Care Stocks - Yahoo Finance
DaVita's New Kidney Research Unveiling Might Change The Case For Investing In DVA - Yahoo Finance
Can DaVita Inc. (TRL) stock retain market dominanceJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
Is DaVita Inc. (TRL) stock testing key supportFed Meeting & Advanced Technical Analysis Signals - newser.com
Technical analysis overview for DaVita Inc. stockRate Hike & Precise Swing Trade Entry Alerts - newser.com
DaVita Launches 'Caring Across Communities' to Support California Nonprofits - Yahoo Finance
Jim Cramer Discusses DaVita’s (DVA) Share Price Movement - MSN
ROCKWELL MEDICAL, INC. SEC 10-Q Report - TradingView
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):